Information for healthcare professionals

Educational Links

Medscape

1. Hypogonadism and Cardiovascular and Metabolic Health: Should We Consider Testosterone Replacement?

Test-and-Teach

This activity is intended to improve physicians’ knowledge regarding the recent clinical data on the benefits of testosterone replacement in hypogonadic men with various comorbid conditions, best practice for the accurate detection and diagnosis of male hypogonadism, and optimal treatment strategies for men with hypogonadism.

  • show all
  • Experts

    Geoffrey Hackett, MD, FRCPI, MRCGPGeoffrey Hackett, MD, FRCPI, MRCGP

    Professor, Heartlands Hospital Birmingham, Birmingham, United Kingdom

  • Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Have increased knowledge of:

      • Hypogonadism in men and its impact on overall health and wellbeing.
      • Recent clinical data on the benefits of testosterone replacement in hypogonadic men with various comorbid conditions.
    • Demonstrate greater competence in their ability to:

      • Accurately detect and diagnose male hypogonadism.
      • Employ best practice in the safe and effective treatment of men with hypogonadism.
  • Target Audience

    This educational activity is intended for an international audience of non-US healthcare professionals, speci­fically diabetologists and endocrinologists, urologists, and primary care physicians involved in the management of patients with, or at risk for, hypogonadism.

2. New Perspectives on Hypogonadism and Testosterone Replacement in Clinical Practice

Expert Column

The goals of this activity are to help participants identify patients with hypogonadism; provide an overview of the impact of the condition on quality of life and mortality; and review the role of testosterone replacement therapy in prostate, metabolic, and cardiovascular health.

  • show all
  • Experts

    Alvaro Morales, MD, FRCSC, FACSAlvaro Morales, MD, FRCSC, FACS

    Professor Emeritus, Department of Urology, School of Medicine, Queen's University, Kingston, Ontario, Canada

    Abraham Morgentaler, MD, FACSAbraham Morgentaler, MD, FACS

    Founder and Director, Men's Health Boston;
    Associate Clinical Professor of Surgery (Urology), Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, United States

    Geoffrey Hackett, MD, FRCPI, MRCGPGeoffrey Hackett, MD, FRCPI, MRCGP

    Professor of Men’s Health, Department of Diabetes, University of Bedfordshire;
    Consultant in Urology, Good Hope Hospital, Sutton Coldfield, United Kingdom

    Michael Zitzmann, MD, PhDMichael Zitzmann, MD, PhD

    Professor of Medicine, Endocrinologist, Andrologist, Diabetologist; Sexual Medicine (FECSM);
    Clinical Andrology, Centre for Reproductive Medicine and Andrology, Münster, Germany

  • Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Identify the clinical impact of testosterone deficiency on men's health, quality of life, and mortality
    • Examine the latest clinical data on the interrelationships between hypogonadism and metabolic and cardiovascular risk factors, and between hypogonadism and prostate health
    • Explain how to identify men at risk, diagnose hypogonadism, and how to treat and monitor patients, taking into account the latest clinical data and guidelines
  • Target Audience

    This educational activity is intended for an international audience of non-US healthcare professionals, speci­fically diabetologists and endocrinologists, urologists, and primary care physicians involved in the management of patients with, or at risk for, hypogonadism.

RESTORE THE MAN

Educational Modules
CPD learning resources covering the Assessment and Management of Hypogonadism are now available via StudyPRN.


There are 3 modules to suit the educational needs of GPs, specialist nurses and secondary care specialists:

epgonline.org

For further information on Hypogonadism also visit

www.epgonline.org/hypogonadism

top of page
Last updated: 2017
G.GM.MH.04.2015.0334